Registration for a live webinar on 'Neuroleptic malignant syndrome' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Disclosures
- Outline
- Background and epidemiology
- Background and epidemiology: risk factors
- Microbiology
- What's in a name?
- Main takeaway points
- Cystitis ('lower UTI')
- Cystitis treatment
- Pyelonephritis ('upper UTI')
- Pyelonephritis treatment
- 7-day vs. 14-day treatment in men
- Febrile UTI
- Important subsets of pyelonephritis and urosepsis
- Emphysematous pyelonephritis imaging
- BPCUS
- Asymptomatic Bacteriuria (ASB)
- Prostatitis
- What is a 'complicated' UTI?
- Summary/take-home points
Topics Covered
- Epidemiology of urinary tract infections (UTI)
- Cystitis
- Pyelonephritis
- Febrile UTI
- Urosepsis
- Emphysematous pyelonephritis
- Bacteriuria/pyuria of clinically undetermined significance (BPCUS)
- Asymptomatic bacteriuria
- Prostatitis
- ‘Complicated’ UTIs
Talk Citation
Drekonja, D. (2023, September 28). Evidence-based treatment of pyelonephritis and other urinary tract infections [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved October 6, 2024, from https://doi.org/10.69645/NJHH9775.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Dimitri Drekonja has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Evidence-based treatment of pyelonephritis and other urinary tract infections
Published on September 28, 2023
34 min
A selection of talks on Infectious Diseases
Transcript
Please wait while the transcript is being prepared...
0:00
Thanks for having me here.
My name is Dimitri Drekonja.
I'm going to be speaking on
evidence-based treatments
of pyelonephritis,
and other urinary
tract infections.
I'm the Chief of
Infectious Diseases here
at the Minneapolis VA
Health Care System.
Also, Associate
Professor of Medicine
at the University of Minnesota.
I come to this from
the perspective
of someone who conducts
clinical trials,
particularly in the area of
urinary tract infections
trying to find really
the best evidence-based
for treating patients
that we see clinically.
0:31
Briefly, for disclosures only
some grant funding from
the Department of
Veterans Affairs,
from VA Merit Review, and from
the VA Cooperative
Studies Program.
No pharmaceutical affiliations.
0:44
This is the outline of what's
going to be covered here.
First, going to go through
some background in
epidemiology of urinary
tract infections.
Then we'll go into
what's in the name.
Really, not everything
that is put
under the moniker
of UTI is the same.
I think it's important
to use precise language
because when we use
that catch-all term,
we lose any of
the specificity that the
different syndromes have and
there's quite a bit of
prognostic information and
treatment information in there.
The specific clinical
syndromes that we'll go over
are cystitis, AKA lower UTI.
Then, moving on to
pyelonephritis,
which also gets the
number of upper UTIs.
Then, we'll move
into febrile UTI,
which has various
sub-classifications
including a couple of important
ones that I have here,
urosepsis, and emphysematous
pyelonephritis.
Something that I'll explain
what the acronym means there.
But we'll call it BPCUS for now.
Then, moving onto
asymptomatic bacteriuria.
I will briefly
mention prostatitis,
which really deserves its own
lecture in its own right.
Finally, going to close
out with a term that
vexes everybody
in the UTI field.
That is the term complicated.
What exactly is a
complicated UTI?
What do we mean by
that? Do people
mean the same things
when they use that term?
Then, we'll summarize
the take-home points and
hopefully, leave with a
good overall understanding.
Hide